A key step to deliver RNAi therapeutics to diverse cell types and tissues beyond the liver from the collaboration of ...
Zacks Small Cap Research on MSN
HURA: Focus on the delta opioid receptor
Updated results from the delta opioid receptor (DOR) program were provided. The content highlighted DOR expression on myeloid-derived suppressor cells (MDSCs) and the effects of DOR inhibition on ...
Novel oral GRK2-biased β2 adrenergic receptor agonists show potential for safer glucose management and obesity treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results